Amprion, Inc. is a biotechnology company based in San Francisco, California, specializing in the development of innovative therapies for neurodegenerative diseases. The company focuses on harnessing the power of protein misfolding and aggregation to create transformative treatments. Amprion's research is centered on advancing the understanding of proteinopathies, with a commitment to addressing unmet medical needs in the field of neurology. Through its cutting-edge technology and scientific expertise, Amprion aims to improve patient outcomes and enhance the quality of life for those affected by these challenging conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#445 in San Francisco, CA

#7,108 in California

#29,839 in US

#55,986 in the World

San Francisco, CA, United States of America

Amprion, Inc.

Forward Citations = 49

14 inventors:

Luis Concha (6 out of 6 patents)

Russell M Lebovitz (6 out of 6 patents)

Benedikt K Vollrath (6 out of 27 patents)

4. Carly Farris (5 out of 5 patents)

5. Mohammad Shahnawaz (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amprion, Inc.. Retrieved from https://idiyas.com/company/amprion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]